Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Credit Suisse Raises Rio Tinto And Cuts BHP

Wed, 07th Dec 2016 09:33

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
CREDIT SUISSE RAISES RIO TINTO TO 'OUTPERFORM' ('NEUTRAL') - PRICE TARGET 3600 PENCE
----------
CREDIT SUISSE CUTS BHP BILLITON TO 'NEUTRAL' ('OUTPERFORM') - PRICE TARGET 1380 PENCE
----------
HSBC CUTS TAYLOR WIMPEY PRICE TARGET TO 179 (220) PENCE - 'BUY'
----------
JPMORGAN RAISES TAYLOR WIMPEY PRICE TARGET TO 200 (195) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS PERSIMMON PRICE TARGET TO 2148 (2640) PENCE - 'BUY'
----------
JPMORGAN RAISES PERSIMMON PRICE TARGET TO 2200 (2000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 495 (470) PENCE - 'NEUTRAL'
----------
HSBC CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 543 (690) PENCE - 'BUY'
----------
RBC CAPITAL CUTS OLD MUTUAL PRICE TARGET TO 160 (180) PENCE - 'UNDERPERFORM'
----------
RBC CAPITAL RAISES ADMIRAL GROUP TARGET TO 1675 (1600) PENCE - 'UNDERPERFORM'
----------
RBC CAPITAL CUTS ST JAMES'S PLACE TARGET TO 950 (1000) PENCE - 'SECTOR PERFORM'
----------
RBC CAPITAL RAISES PRUDENTIAL PRICE TARGET TO 1550 (1440) PENCE - 'SECTOR PERFORM'
----------
Barclays Cuts Worldpay Target To 315p From 350p, Maintains Overweight
----------
JPMORGAN CUTS TRAVIS PERKINS PRICE TARGET TO 1625 (1715) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES ASHTEAD GROUP PRICE TARGET TO 1660 (1430) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS IMPERIAL BRANDS PRICE TARGET TO 3640 (3660) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BUNZL PRICE TARGET TO 2200 (2400) PENCE - 'NEUTRAL'
----------
S&P GLOBAL RAISES WOLSELEY PRICE TARGET TO 5500 (4800) PENCE - 'BUY'
----------
UBS CUTS SHIRE TO 'NEUTRAL' ('BUY') - TARGET 5000 (5600) PENCE
----------
UBS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1600 (1650) PENCE - 'NEUTRAL'
----------
UBS CUTS ASTRAZENECA PRICE TARGET TO 5000 (5480) PENCE - 'BUY'
----------
JPMORGAN CUTS UNILEVER TO 'NEUTRAL' (OVERWEIGHT) - PRICE TARGET 3200 (4100) PENCE
----------
JPMORGAN CUTS RECKITT BENCKISER PRICE TARGET TO 6750 (7100) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY CUTS STANDARD CHARTERED TARGET TO 520 (555) PENCE - 'UNDERWEIGHT'
----------
MORGAN STANLEY RAISES BARCLAYS PRICE TARGET TO 230 (190) PENCE - 'EQUAL-WEIGHT'
----------
FTSE 250
----------
RBC CAPITAL RAISES ESURE GROUP PRICE TARGET TO 185 (180) PENCE - 'UNDERPERFORM'
----------
RBC CAPITAL RAISES LANCASHIRE TARGET TO 650 (625) PENCE - 'SECTOR PERFORM'
----------
RBC CAPITAL CUTS HISCOX PRICE TARGET TO 1150 (1200) PENCE - 'SECTOR PERFORM'
----------
RBC CAPITAL RAISES HASTINGS PRICE TARGET TO 240 (225) PENCE - 'SECTOR PERFORM'
----------
RBC CAPITAL RAISES BEAZLEY PRICE TARGET TO 475 (450) PENCE - 'OUTPERFORM'
----------
Barclays Lifts Paysafe Target To 610p From 560p, Maintains Overweight
----------
Barclays Cuts PayPoint To Underweight From Equal-Weight Ups Price Target To 950p From 1,030p
----------
DEUTSCHE BANK RAISES VICTREX PRICE TARGET TO 1700 (1650) PENCE - 'HOLD'
----------
BERENBERG RAISES VICTREX PRICE TARGET TO 1800 (1650) PENCE - 'HOLD'
----------
JPMORGAN RAISES VICTREX PRICE TARGET TO 1550 (1500) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES REDROW PRICE TARGET TO 425 (360) PENCE - 'NEUTRAL
----------
JPMORGAN RAISES KAZ MINERALS PRICE TARGET TO 220 (215) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES IBSTOCK PRICE TARGET TO 210 (170) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES CREST NICHOLSON PRICE TARGET TO 590 (550) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES COUNTRYSIDE PRICE TARGET TO 275 (250) PENCE - 'NEUTRAL
----------
JPMORGAN CUTS SIG TO 'UNDERWEIGHT' ('NEUTRAL')
----------
LIBERUM CUTS CARILLION PRICE TARGET TO 200 (250) PENCE - 'HOLD'
----------
UBS RAISES KAZ MINERALS PRICE TARGET TO 465 (450) PENCE - 'BUY'
----------
UBS CUTS BRITVIC PRICE TARGET TO 700 (760) PENCE - 'BUY'
----------
HSBC CUTS REDROW PRICE TARGET TO 493 (630) PENCE - 'BUY'
----------
HSBC CUTS MCCARTHY & STONE PRICE TARGET TO 221 (330) PENCE - 'BUY'
----------
HSBC CUTS CREST NICHOLSON PRICE TARGET TO 745 (830) PENCE - 'BUY'
----------
JPMORGAN RAISES BOVIS HOMES PRICE TARGET TO 1070 (1000) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS BOVIS HOMES PRICE TARGET TO 1219 (1450) PENCE - 'BUY'
----------
HSBC CUTS BERKELEY GROUP PRICE TARGET TO 3481 (4300) PENCE - 'BUY'
----------
JPMORGAN RAISES BERKELEY GROUP PRICE TARGET TO 3400 (3200) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS BELLWAY PRICE TARGET TO 3745 (3840) PENCE - 'BUY'
----------
JPMORGAN RAISES BELLWAY PRICE TARGET TO 2950 (2680) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES GALLIFORD TRY PRICE TARGET TO 1930 (1800) PENCE - 'BUY'
----------
GOLDMAN CUTS CMC MARKETS PRICE TARGET TO 130 (255) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS ULTRA ELECTRONICS PRICE TARGET TO 2175 (2185) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY CUTS MITCHELLS & BUTLERS TO 'EQUAL-WEIGHT' ('OVERWEIGHT'); TARGET 260 (340) PENCE
----------
MORGAN STANLEY CUTS GREENE KING TARGET TO 700 (790) PENCE - 'EQUAL-WEIGHT'
----------
MAIN MARKET AND AIM
----------
DEUTSCHE BANK RAISES IMAGINATION TECHNOLOGIES PRICE TARGET TO 170 (110) PENCE - 'SELL'
----------
HSBC RAISES HILTON FOOD PRICE TARGET TO 690 (680) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.